IL193025A0 - Crystalline forms of ciclesonide - Google Patents

Crystalline forms of ciclesonide

Info

Publication number
IL193025A0
IL193025A0 IL193025A IL19302508A IL193025A0 IL 193025 A0 IL193025 A0 IL 193025A0 IL 193025 A IL193025 A IL 193025A IL 19302508 A IL19302508 A IL 19302508A IL 193025 A0 IL193025 A0 IL 193025A0
Authority
IL
Israel
Prior art keywords
ciclesonide
crystalline forms
crystalline
forms
Prior art date
Application number
IL193025A
Original Assignee
Levi Sigalit
Sicor Inc
Aronhime Judith
Rossetto Pierluigi
Macdonald Peter Lindsay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Levi Sigalit, Sicor Inc, Aronhime Judith, Rossetto Pierluigi, Macdonald Peter Lindsay filed Critical Levi Sigalit
Publication of IL193025A0 publication Critical patent/IL193025A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL193025A 2006-02-08 2008-07-24 Crystalline forms of ciclesonide IL193025A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77165406P 2006-02-08 2006-02-08
US77384106P 2006-02-15 2006-02-15
PCT/US2007/003405 WO2007092574A2 (en) 2006-02-08 2007-02-07 Crystalline forms of ciclesonide

Publications (1)

Publication Number Publication Date
IL193025A0 true IL193025A0 (en) 2009-02-11

Family

ID=38330141

Family Applications (1)

Application Number Title Priority Date Filing Date
IL193025A IL193025A0 (en) 2006-02-08 2008-07-24 Crystalline forms of ciclesonide

Country Status (5)

Country Link
EP (1) EP1904514A2 (en)
JP (1) JP2009526068A (en)
CA (1) CA2637815A1 (en)
IL (1) IL193025A0 (en)
WO (1) WO2007092574A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
CN106883283B (en) * 2015-12-15 2021-02-02 天津金耀集团有限公司 Ciclesonide monohydrate, crystal form and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0745512B2 (en) * 1986-10-21 1995-05-17 タマ生化学株式会社 Method for concentrating and purifying oryzanol constituents
GR1001529B (en) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Process for the obtainment of a new pregna-1,4-diene-3,20-dione -16-17-acetal-21 esters
JPH07146125A (en) * 1993-11-26 1995-06-06 Hitachi Zosen Corp Straightness measuring apparatus
DE19635498A1 (en) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Process for epimer enrichment
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
EP1670482B2 (en) * 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
JP2005251505A (en) * 2004-03-03 2005-09-15 Teijirou Azuma Proton conductor
EP1869064A2 (en) * 2005-11-02 2007-12-26 Sicor, Inc. Improved process for the preparation of ciclesonide

Also Published As

Publication number Publication date
WO2007092574A2 (en) 2007-08-16
CA2637815A1 (en) 2007-08-16
EP1904514A2 (en) 2008-04-02
WO2007092574A3 (en) 2007-10-18
JP2009526068A (en) 2009-07-16

Similar Documents

Publication Publication Date Title
HK1200440A1 (en) Crystalline forms of inhibitor
DK2035004T3 (en) Phenylsubstituerede pyrazinoylguanidin-natriumkanalblokkere med beta-agonistaktivitet
GB0819182D0 (en) Crystalline forms
AP2527A (en) Pyrazoline compounds as mineralocorticoid receptorantagonists
IL198266A0 (en) Crystalline modification of fipronil
IL183380A0 (en) Crystalline forms of linezolid intermediate
ZA200903970B (en) Crystalline modification of fipronil
ZA200903967B (en) Crystalline modification of fipronil
HK1164698A1 (en) Crystalline forms of genistein
HK1129287A1 (en) Towel
ZA200903614B (en) New crystalline forms
ZA200903972B (en) Crystalline modification of fipronil
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
GB0611558D0 (en) Towel
GB0710680D0 (en) Novel crystalline form of olmesartan medoxmil
IL195061A0 (en) Crystalline forms of atorvastatin
PL2173710T3 (en) Novel crystalline form
IL193025A0 (en) Crystalline forms of ciclesonide
ZA200806859B (en) Novel crystalline compounds
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
GB0606452D0 (en) Purification of salts
PL1886669T3 (en) Phosphoglucan based immunotrophic preparation for the treatment of adenotonsillar hypertrophy
AU2006902495A0 (en) Dermitology health formula
AU2006901754A0 (en) Healthwatch Advanced health watch
AU309823S (en) Timer